Balance Sheet Data
AC Immune SA (ACIU)
$2.22
-0.09 (-3.90%)
Year A/P | 2017 Actual | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected |
| Total Cash | 124.38 | 186.46 | 288.59 | 225.89 | 198.22 | 4,498.85 | 23,884.85 | 126,807.02 | 673,231 | 3,574,249.73 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | 3.72 | 4.10 | 1.40 | 1.92 | 1.40 | 78.97 | 419.28 | 2,226 | 11,818.06 | 62,743.25 |
| Account Receivables (%) | ||||||||||
| Inventories | - | - | - | - | - | - | - | - | - | - |
| Inventories (%) | ||||||||||
| Accounts Payable | 1.09 | 1.98 | 0.14 | 2.18 | 2 | 43.17 | 229.19 | 1,216.80 | 6,460.13 | 34,297.46 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -1.80 | -1.86 | -1.89 | -1.71 | -2.63 | -44.10 | -234.12 | -1,242.97 | -6,599.03 | -35,034.90 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.